Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

301 Views

A1. Novel Agents

Poster Session: Novel Agents

(P-1075) Treatment Patterns among Hospitalized Patients with Gram-Negative Infection Treated with Imipenem/Cilastatin/Relebactam (I/R): Retrospective US-based EHR Medical Chart Review

Friday, October 18, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

Emre Yucel, PhD

Principal Scientist
Merck & Co., Inc.
North Wales, Pennsylvania, United States

Co-Author(s)

LL

Lulu Lee, PhD

Oracle Life Sciences
Los Angeles, California, United States
KM

Kushal Modi, MS

Oracle Life Sciences
Los Angeles, California, United States
YZ

Yanbing Zhou, PhD

Merck
Rahway, New Jersey, United States
Ryan K. Shields, PharmD, MS

Associate Professor of Medicine
University of Pittsburgh
Pittsburgh, Pennsylvania, United States